Prawo i regulacje · 31/01/2022

Federal Judge Approves Pfizer's Acquisition of Mylan Pharmaceuticals, Rejects Erythropoietin Biosimilar Proposal

U.S. District Judge Bradley H. Chesler has approved Pfizer's acquisition of Mylan Pharmaceuticals, rejecting a proposal for a biosimilar version of Mylan's erythropoietin product, which is used to treat anemia in patients with chronic kidney disease.